Oncolytic virotherapy armed with an engineered interfering lncRNA exhibits antitumor activity by blocking the epithelial mesenchymal transition in triple-negative breast cancer.

[1]  Li Yan,et al.  MMP2/3 promote the growth and migration of laryngeal squamous cell carcinoma via PI3K/Akt‐NF‐κB‐mediated epithelial–mesenchymal transformation , 2019, Journal of cellular physiology.

[2]  Wei Sun,et al.  FOXO3a knockdown promotes radioresistance in nasopharyngeal carcinoma by inducing epithelial-mesenchymal transition and the Wnt/β-catenin signaling pathway. , 2019, Cancer letters.

[3]  Ning Zhang,et al.  Epigenetic regulation of NAMPT by NAMPT-AS drives metastatic progression in triple-negative breast cancer. , 2019, Cancer research.

[4]  T. Padilla-Benavides,et al.  Extracellular-Signal Regulated Kinase: A Central Molecule Driving Epithelial–Mesenchymal Transition in Cancer , 2019, International journal of molecular sciences.

[5]  P. ten Dijke,et al.  Epigenetic Reprogramming of TGF-β Signaling in Breast Cancer , 2019, Cancers.

[6]  Y. Bidet,et al.  New Insights into the Implication of Epigenetic Alterations in the EMT of Triple Negative Breast Cancer , 2019, Cancers.

[7]  John N. Hutchinson,et al.  Interferon Signaling is Diminished with Age and is Associated with Immune Checkpoint Blockade Efficacy in Triple-Negative Breast Cancer. , 2019, Cancer discovery.

[8]  Wenbin Zhou,et al.  miR-3178 inhibits cell proliferation and metastasis by targeting Notch1 in triple-negative breast cancer , 2018, Cell Death & Disease.

[9]  T. Klonisch,et al.  Inhibitor of DNA Binding 2 Inhibits Epithelial-Mesenchymal Transition via Up-Regulation of Notch3 in Breast Cancer , 2018, Translational oncology.

[10]  S. Orrù,et al.  Molecular Signatures of the Insulin-Like Growth Factor 1-Mediated Epithelial-Mesenchymal Transition in Breast, Lung and Gastric Cancers , 2018, International journal of molecular sciences.

[11]  J. Wan,et al.  Fisetin Inhibited Growth and Metastasis of Triple-Negative Breast Cancer by Reversing Epithelial-to-Mesenchymal Transition via PTEN/Akt/GSK3β Signal Pathway , 2018, Front. Pharmacol..

[12]  A. Musti,et al.  Crosstalk between Notch, HIF-1α and GPER in Breast Cancer EMT , 2018, International journal of molecular sciences.

[13]  R. Kordek,et al.  MicroRNAs in regulation of triple-negative breast cancer progression , 2018, Journal of Cancer Research and Clinical Oncology.

[14]  E. Barillot,et al.  Identification of microRNA clusters cooperatively acting on epithelial to mesenchymal transition in triple negative breast cancer , 2018, bioRxiv.

[15]  Xiaojia Wang,et al.  Bioinformatics identification of dysregulated microRNAs in triple negative breast cancer based on microRNA expression profiling , 2017, Oncology letters.

[16]  T. Ye,et al.  MiR-22 down-regulates the proto-oncogene ATP citrate lyase to inhibit the growth and metastasis of breast cancer. , 2018, American journal of translational research.

[17]  Yul Ri Chung,et al.  Prognostic value of microRNA-9 and microRNA-155 expression in triple-negative breast cancer. , 2017, Human pathology.

[18]  Rui Zhang,et al.  Long non-coding RNA XIST regulates PDCD4 expression by interacting with miR-21-5p and inhibits osteosarcoma cell growth and metastasis , 2017, International journal of oncology.

[19]  Guan-Jhong Huang,et al.  3,4-Dihydroxybenzalactone Suppresses Human Non-Small Cell Lung Carcinoma Cells Metastasis via Suppression of Epithelial to Mesenchymal Transition, ROS-Mediated PI3K/AKT/MAPK/MMP and NFκB Signaling Pathways , 2017, Molecules.

[20]  Yongjie Zhang,et al.  Desulfation of cell surface HSPG is an effective strategy for the treatment of gallbladder carcinoma. , 2016, Cancer letters.

[21]  De Chen,et al.  Down‐regulation of TRPS1 stimulates epithelial–mesenchymal transition and metastasis through repression of FOXA1 , 2016, The Journal of pathology.

[22]  J. Meléndez-Zajgla,et al.  miR‐10b expression in breast cancer stem cells supports self‐renewal through negative PTEN regulation and sustained AKT activation , 2016, EMBO reports.

[23]  S. Alahari,et al.  Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications , 2016, Molecular Cancer.

[24]  I. Voutsadakis.  Epithelial-Mesenchymal Transition (EMT) and Regulation of EMT Factors by Steroid Nuclear Receptors in Breast Cancer: A Review and in Silico Investigation , 2016, Journal of clinical medicine.

[25]  Yan Shen,et al.  Identification of dysregulated microRNAs in triple-negative breast cancer (review). , 2015, International journal of oncology.

[26]  Lei Wang,et al.  Upregulated microRNA-301a in breast cancer promotes tumor metastasis by targeting PTEN and activating Wnt/β-catenin signaling. , 2014, Gene.

[27]  T. Sellers,et al.  Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer , 2013, Oncogene.

[28]  Can Xu,et al.  MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways. , 2013, Cancer letters.

[29]  Jungsuk An,et al.  Epithelial–mesenchymal transition in breast cancer correlates with high histological grade and triple‐negative phenotype , 2012, Histopathology.

[30]  Zhiming Wang,et al.  miR-21 promotes migration and invasion by the miR-21-PDCD4-AP-1 feedback loop in human hepatocellular carcinoma. , 2012, Oncology reports.

[31]  Hai-Meng Zhou,et al.  HSulf‐1 inhibits cell proliferation and invasion in human gastric cancer , 2011, Cancer science.

[32]  Jung lim Kim,et al.  Metastatic function of BMP-2 in gastric cancer cells: the role of PI3K/AKT, MAPK, the NF-κB pathway, and MMP-9 expression. , 2011, Experimental cell research.

[33]  Ru-Fang Yeh,et al.  TRPS1 Targeting by miR-221/222 Promotes the Epithelial-to-Mesenchymal Transition in Breast Cancer , 2011, Science Signaling.

[34]  K. Zatloukal,et al.  miR‐29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis , 2009, EMBO reports.

[35]  Domenico Coppola,et al.  MicroRNA-155 Is Regulated by the Transforming Growth Factor β/Smad Pathway and Contributes to Epithelial Cell Plasticity by Targeting RhoA , 2008, Molecular and Cellular Biology.

[36]  Andreas Sommer,et al.  NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression , 2004 .

[37]  H. Pehamberger,et al.  NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. , 2004, The Journal of clinical investigation.